Samsung Bioepis ventures into novel R&D with Takeda deal
Samsung Bioepis is joining forces with Takeda Pharmaceutical to jointly fund and co-develop multiple novel biologic therapies in unmet disease areas, taking its first step towards developing new pharmaceuticals.
Read More
